MX2021010739A - Celulas madre mesenquimales inmunomoduladoras. - Google Patents
Celulas madre mesenquimales inmunomoduladoras.Info
- Publication number
- MX2021010739A MX2021010739A MX2021010739A MX2021010739A MX2021010739A MX 2021010739 A MX2021010739 A MX 2021010739A MX 2021010739 A MX2021010739 A MX 2021010739A MX 2021010739 A MX2021010739 A MX 2021010739A MX 2021010739 A MX2021010739 A MX 2021010739A
- Authority
- MX
- Mexico
- Prior art keywords
- mesenchymal stem
- cell
- immunomodulating
- stem cells
- current invention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/03—Compounds acting on the NO pathway, e.g. nitrososarginine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/231—Interleukin-10 (IL-10)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19162270 | 2019-03-12 | ||
| PCT/EP2020/056625 WO2020182935A1 (en) | 2019-03-12 | 2020-03-12 | Immunomodulating mesenchymal stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021010739A true MX2021010739A (es) | 2021-12-15 |
Family
ID=65801891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021010739A MX2021010739A (es) | 2019-03-12 | 2020-03-12 | Celulas madre mesenquimales inmunomoduladoras. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20220154147A1 (https=) |
| EP (1) | EP3938494A1 (https=) |
| JP (1) | JP7572367B2 (https=) |
| KR (1) | KR20210139259A (https=) |
| CN (1) | CN113677789B (https=) |
| AU (1) | AU2020235912A1 (https=) |
| BR (1) | BR112021017738A8 (https=) |
| CA (1) | CA3132414A1 (https=) |
| MX (1) | MX2021010739A (https=) |
| WO (1) | WO2020182935A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021267900A1 (en) | 2020-05-08 | 2023-01-19 | Gallant Pet Inc. | Uterine-derived regenerative cell compositions and uses thereof |
| CN117835995A (zh) | 2021-07-08 | 2024-04-05 | 勃林格殷格翰比利时兽医公司 | 用于治疗慢性龈口炎的间充质干细胞 |
| EP4366743A1 (en) * | 2021-07-08 | 2024-05-15 | Boehringer Ingelheim Veterinary Medicine Belgium | Mesenchymal stem cells for use in the treatment of osteoarthritis in animals |
| TW202319536A (zh) | 2021-07-08 | 2023-05-16 | 比利時商比利時百靈佳殷格翰動物醫藥公司 | 用於治療慢性腎病之間葉幹細胞 |
| CN117897165A (zh) * | 2021-07-08 | 2024-04-16 | 勃林格殷格翰比利时兽医公司 | 用于治疗特应性皮炎的间充质干细胞 |
| EP4568687A1 (en) | 2022-08-11 | 2025-06-18 | Boehringer Ingelheim Vetmedica GmbH | Mesenchymal stem cells for use in the treatment of insect-bite hypersensitivity in equines |
| WO2024133886A1 (en) * | 2022-12-23 | 2024-06-27 | Boehringer Ingelheim Veterinary Medicine Belgium | Primed mesenchymal stem cells for use in the treatment of chronic kidney disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6328960B1 (en) | 1998-03-18 | 2001-12-11 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| EP3461884B1 (en) * | 2004-03-22 | 2025-05-28 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| US20140017787A1 (en) * | 2010-10-11 | 2014-01-16 | Aline M. Betancourt | Mesenchymal stem cells and related therapies |
| ITRM20110403A1 (it) * | 2011-07-28 | 2013-01-29 | Ospedale Pediatrico Bambino Gesu | Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori. |
| SI2785359T1 (sl) * | 2011-11-30 | 2018-11-30 | Astellas Institute For Regenerative Medicine | Mezenhimske stromalne celice in uporabe povezane z njimi |
| AU2017235446A1 (en) | 2016-03-16 | 2018-11-08 | Cell Medicine, Inc. | Mesenchymal stem cells with enhanced efficacy |
| US20220333197A1 (en) * | 2019-01-31 | 2022-10-20 | Primegen Biotech, Llc | Treatment of Atopic Dermatitis Using Mesenchymal Stem Cells and Immune Modulation |
-
2020
- 2020-03-12 US US17/436,640 patent/US20220154147A1/en not_active Abandoned
- 2020-03-12 CN CN202080018981.6A patent/CN113677789B/zh active Active
- 2020-03-12 BR BR112021017738A patent/BR112021017738A8/pt unknown
- 2020-03-12 AU AU2020235912A patent/AU2020235912A1/en active Pending
- 2020-03-12 WO PCT/EP2020/056625 patent/WO2020182935A1/en not_active Ceased
- 2020-03-12 JP JP2021553068A patent/JP7572367B2/ja active Active
- 2020-03-12 EP EP20708513.5A patent/EP3938494A1/en active Pending
- 2020-03-12 CA CA3132414A patent/CA3132414A1/en active Pending
- 2020-03-12 MX MX2021010739A patent/MX2021010739A/es unknown
- 2020-03-12 KR KR1020217029168A patent/KR20210139259A/ko not_active Ceased
-
2024
- 2024-12-23 US US18/999,942 patent/US20250122477A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250122477A1 (en) | 2025-04-17 |
| EP3938494A1 (en) | 2022-01-19 |
| JP2022524764A (ja) | 2022-05-10 |
| KR20210139259A (ko) | 2021-11-22 |
| CN113677789B (zh) | 2024-11-01 |
| US20220154147A1 (en) | 2022-05-19 |
| BR112021017738A8 (pt) | 2022-08-02 |
| AU2020235912A1 (en) | 2021-10-07 |
| CA3132414A1 (en) | 2020-09-17 |
| WO2020182935A1 (en) | 2020-09-17 |
| CN113677789A (zh) | 2021-11-19 |
| JP7572367B2 (ja) | 2024-10-23 |
| BR112021017738A2 (https=) | 2021-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021010739A (es) | Celulas madre mesenquimales inmunomoduladoras. | |
| SA519401455B1 (ar) | طريقة لعزل الخلايا الجذعية اللحمية المتوسطية من الغشاء السلوي للحبل السري باستخدام مستنبت خلايا متوسطية | |
| BR112021015887A8 (pt) | Método para criopreservação de célula-tronco, população de células-tronco, composição de criopreservação, uso de nac, e kit de criopreservação | |
| PH12022550373A1 (en) | Ex vivo gamma delta t cell populations | |
| MY192561A (en) | Taurine supplemented cell culture medium and methods of use | |
| MX2019005476A (es) | Ensayo de celulas madre pluripotentes. | |
| GB2548740A (en) | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same | |
| BR112015030946A8 (pt) | composição compreendendo uma célula ß pancreática não-nativa, método de diferenciação de células progenitoras em células ß pancreáticas in vitro e uso de uma célula ß pancreática não-nativa | |
| MX2022008715A (es) | Medio libre de suero y metodo de cultivo adecuado para el cultivo de celulas sanguineas, incluidas celulas madre hematopoyeticas humanas. | |
| PH12020551584A1 (en) | Stem/progenitor cells from duodenal brunner's glands and methods of isolating and using them | |
| PH12014501175B1 (en) | Medium composition for rejuvenating stem cells | |
| WO2023039567A3 (en) | Compositions of induced pluripotent stem cell-derived cells and methods of use thereof | |
| MX2021012041A (es) | Metodos para promover la diferenciacion de celulas epiteliales timicas y progenitores de celulas epiteliales timicas de celulas madre pluripotentes, celulas resultantes y usos de estas. | |
| EA201791233A1 (ru) | Материал стволовых клеток и способ его получения | |
| PH12018502061A1 (en) | Differentiation of pluripotent stem cells to intestinal midgut endoderm cells | |
| HRP20170216T1 (hr) | Populacija ljudskih matičnih stanica vrata maternice i njihova uporaba | |
| WO2019088480A3 (ko) | 에티오나마이드를 이용한 줄기세포 이동성 향상 방법 | |
| KR102306236B9 (ko) | 유도만능줄기세포 유래 세포치료제의 치료 효율 및 성능 향상을 위한 중간엽 줄기세포 기반 패치 적용 기술 | |
| ZA202107808B (en) | Cell culture medium for eukaryotic cells | |
| AU2019356414A8 (en) | Binding proteins specific for HA-1H and uses thereof | |
| EA202190758A1 (ru) | Композиция для индукции гибели клеток, имеющих мутированный ген, и способ индукции гибели клеток, имеющих мутированный ген, с применением композиции | |
| AU2020363707A8 (en) | In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response | |
| SG11201900989QA (en) | Method for inducing differentiation of pluripotent stem cells in vitro | |
| WO2021011779A3 (en) | Mesenchymal stem cell compositions | |
| WO2019204494A3 (en) | Date palm medium compositions and methods |